NCT03906721View on ClinicalTrials.gov

Reduction of Opioid Dose Using Conditioning & Open-Label Placebo (COLP) in Patients With Spinal Cord Injury, Polytrauma and Burn Injury

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 20, 2019

Primary Completion Date

November 1, 2021

Study Completion Date

November 1, 2021

Conditions
Spinal Cord InjuriesPolytraumaBurn Injury
Interventions
DRUG

Placebo

Sugar pill used to condition patients.

DRUG

Oxycodone

An opioid used for analgesia.

OTHER

Essential Oil

An aromatic oil used for conditioning.

Trial Locations (1)

02129

Spaulding Rehabilitation Hospital, Charlestown

All Listed Sponsors
lead

Spaulding Rehabilitation Hospital

OTHER

NCT03906721 - Reduction of Opioid Dose Using Conditioning & Open-Label Placebo (COLP) in Patients With Spinal Cord Injury, Polytrauma and Burn Injury | Biotech Hunter | Biotech Hunter